	US 12,220,388 B2
	Uses of curcuminoid compositions
Pascale Elizabeth Renée Fanca-Berthon, Le Thor (FR); Leila Denise Falcao, Avignon (FR); Mathieu Tenon, Malemort du comtat (FR); Maryline Vinal, Caumont sur Durance (FR); and Simona Birtic, Cavaillon (FR)
Assigned to Givaudan France Naturals SAS, Avignon (FR)
Filed by Givaudan France Naturals SAS, Avignon (FR)
Filed on Nov. 13, 2023, as Appl. No. 18/388,981.
Application 18/388,981 is a continuation of application No. 17/266,320, granted, now 12,059,394, previously published as PCT/EP2019/071055, filed on Aug. 5, 2019.
Claims priority of application No. 1812776 (GB), filed on Aug. 6, 2018; and application No. 1902266 (GB), filed on Feb. 19, 2019.
Prior Publication US 2024/0115519 A1, Apr. 11, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/12 (2006.01); A61K 36/185 (2006.01); A61K 47/36 (2006.01)

CPC A61K 31/12 (2013.01) [A61K 36/185 (2013.01); A61K 47/36 (2013.01)]

17 Claims

1. A method for administering a substantially dry emulsion to a human consisting essentially of administering the substantially dry emulsion consisting essentially of (i) a turmeric extract, (ii) a quillaja extract, and (iii) gum arabic.